Landec Corporation  

(Public, NASDAQ:LNDC)   Watch this stock  
Find more results for LNDC
12.16
+0.01 (0.08%)
After Hours: 12.16 0.00 (0.00%)
Apr 23, 5:09PM EDT  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 12.13 - 12.31
52 week 9.84 - 15.96
Open 12.13
Vol / Avg. 104,047.00/138,270.00
Mkt cap 325.65M
P/E 17.22
Div/yield     -
EPS 0.71
Shares 26.78M
Beta 1.03
Inst. own 93%
Jun 10, 2014
Landec Corporation at Piper Jaffray Consumer Conference Add to calendar
Mar 26, 2014
Q3 2014 Landec Corporation Earnings Conference Call
Mar 25, 2014
Q3 2014 Landec Corporation Earnings Release
Mar 12, 2014
Landec Corporation at ROTH Conference
More events from DailyFinance »    

Key stats and ratios

Q1 (Feb '14) 2013
Net profit margin 5.08% 5.16%
Operating margin 7.70% 5.63%
EBITD margin - 7.28%
Return on average assets 8.46% 8.02%
Return on average equity 13.28% 13.75%
Employees 526 -
CDP Score - -

Address

3603 Haven Avenue
MENLO PARK, CA 94025
United States - Map
+1-650-3061650 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Landec Corporation (Landec) designs, develops, manufactures and sells polymer products for food and agricultural products, medical devices and licensed partner applications that incorporate Landec's polymer technologies. The Company has two polymer technology platforms: Intelimer polymers, and hyaluronan (HA) biopolymers. The Intelimer polymer is a crystalline, hydrophobic polymer. Hyaluronan is a non-crystalline, hydrophilic polymer. Landec operates in four business segments: Apio, Inc. (Apio) with the Food Products Technology and Food Export businesses, Lifecore Biomedical, Inc., with the HA Biomaterials business and Landec's Technology Licensing business. On April 23, 2012, Apio acquired GreenLine Holding Company (GreenLine). On June 24, 2012, the Company sold Landec Ag LLC to INCOTEC Holding North America, Inc.

Officers and directors

Gary T. Steele Chairman of the Board, President, Chief Executive Officer
Age: 64
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Gregory S. Skinner Chief Financial Officer, Vice President - Finance and Administration
Age: 52
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Nicholas Tompkins Chairman of the Board of Apio, Inc., Director
Age: 58
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Molly A. Hemmeter Chief Operating Officer
Age: 46
Bio & Compensation  - Reuters
Steven P. Bitler Ph.D. Vice President - Corporate Technology
Age: 55
Bio & Compensation  - Reuters
Ronald Lane Midyett Vice President; President, Chief Executive Officer of Apio, Inc.
Age: 47
Bio & Compensation  - Reuters
Stephen E. Halprin Lead Independent Director
Age: 75
Bio & Compensation  - Reuters
Frederick Frank Independent Director
Age: 81
Bio & Compensation  - Reuters
Steven D. Goldby Independent Director
Age: 73
Bio & Compensation  - Reuters
Dean Hollis Independent Director
Age: 53
Bio & Compensation  - Reuters